387 related articles for article (PubMed ID: 35493371)
1. Epidemiology, Drug Susceptibility, and Clinical Risk Factors in Patients With Invasive Aspergillosis.
Wang Y; Zhang L; Zhou L; Zhang M; Xu Y
Front Public Health; 2022; 10():835092. PubMed ID: 35493371
[TBL] [Abstract][Full Text] [Related]
2. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
[TBL] [Abstract][Full Text] [Related]
3. Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.
van Ingen J; van der Lee HA; Rijs TA; Zoll J; Leenstra T; Melchers WJ; Verweij PE
J Antimicrob Chemother; 2015 Jan; 70(1):178-81. PubMed ID: 25301884
[TBL] [Abstract][Full Text] [Related]
4. First azole-resistant Aspergillus fumigatus isolates with the environmental TR
Ahangarkani F; Puts Y; Nabili M; Khodavaisy S; Moazeni M; Salehi Z; Laal Kargar M; Badali H; Meis JF
Mycoses; 2020 May; 63(5):430-436. PubMed ID: 32056319
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype complexity of the TR46/Y121F/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus.
Snelders E; Camps SM; Karawajczyk A; Rijs AJ; Zoll J; Verweij PE; Melchers WJ
Fungal Genet Biol; 2015 Sep; 82():129-35. PubMed ID: 26092193
[TBL] [Abstract][Full Text] [Related]
6. First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.
Astvad KM; Jensen RH; Hassan TM; Mathiasen EG; Thomsen GM; Pedersen UG; Christensen M; Hilberg O; Arendrup MC
Antimicrob Agents Chemother; 2014 Sep; 58(9):5096-101. PubMed ID: 24936595
[TBL] [Abstract][Full Text] [Related]
7. Azole resistance in Aspergillus species in Southern Taiwan: An epidemiological surveillance study.
Chen YC; Kuo SF; Wang HC; Wu CJ; Lin YS; Li WS; Lee CH
Mycoses; 2019 Dec; 62(12):1174-1181. PubMed ID: 31549427
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients.
Fischer J; van Koningsbruggen-Rietschel S; Rietschel E; Vehreschild MJ; Wisplinghoff H; Krönke M; Hamprecht A
J Antimicrob Chemother; 2014 Jun; 69(6):1533-6. PubMed ID: 24486872
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
[TBL] [Abstract][Full Text] [Related]
10. Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46/Y121F/T289A cyp51A mutation.
Siopi M; Rivero-Menendez O; Gkotsis G; Panara A; Thomaidis NS; Alastruey-Izquierdo A; Pournaras S; Meletiadis J
J Antimicrob Chemother; 2020 Nov; 75(11):3181-3188. PubMed ID: 32814940
[TBL] [Abstract][Full Text] [Related]
11. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
[TBL] [Abstract][Full Text] [Related]
12. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.
Steinmann J; Hamprecht A; Vehreschild MJ; Cornely OA; Buchheidt D; Spiess B; Koldehoff M; Buer J; Meis JF; Rath PM
J Antimicrob Chemother; 2015 May; 70(5):1522-6. PubMed ID: 25630644
[TBL] [Abstract][Full Text] [Related]
13. Multi-azole resistant Aspergillus fumigatus harboring Cyp51A TR46/Y121F/T289A isolated in Japan.
Hagiwara D; Takahashi H; Fujimoto M; Sugahara M; Misawa Y; Gonoi T; Itoyama S; Watanabe A; Kamei K
J Infect Chemother; 2016 Aug; 22(8):577-9. PubMed ID: 26898666
[TBL] [Abstract][Full Text] [Related]
14. Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in
Rivero-Menendez O; Soto-Debran JC; Medina N; Lucio J; Mellado E; Alastruey-Izquierdo A
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285229
[TBL] [Abstract][Full Text] [Related]
15. Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.
Gonzalez-Lara MF; Roman-Montes CM; Diaz-Lomeli P; Rangel-Cordero A; Valenzuela MO; Ponce-de-Leon A; Sifuentes-Osornio J; Ostrosky-Zeichner L; Martinez-Gamboa A
J Antimicrob Chemother; 2019 Jul; 74(7):2047-2050. PubMed ID: 31220262
[TBL] [Abstract][Full Text] [Related]
16. Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013.
van Paassen J; Russcher A; In 't Veld-van Wingerden AW; Verweij PE; Kuijper EJ
Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27541498
[TBL] [Abstract][Full Text] [Related]
17. Azole-resistant Aspergillus fumigatus: A global phenomenon originating in the environment?
Jeanvoine A; Rocchi S; Bellanger AP; Reboux G; Millon L
Med Mal Infect; 2020 Aug; 50(5):389-395. PubMed ID: 31472992
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
Buil JB; Rijs AJMM; Meis JF; Birch M; Law D; Melchers WJG; Verweij PE
J Antimicrob Chemother; 2017 Sep; 72(9):2548-2552. PubMed ID: 28605488
[TBL] [Abstract][Full Text] [Related]
19. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain.
Escribano P; Rodríguez-Sánchez B; Díaz-García J; Martín-Gómez MT; Ibáñez-Martínez E; Rodríguez-Mayo M; Peláez T; García-Gómez de la Pedrosa E; Tejero-García R; Marimón JM; Reigadas E; Rezusta A; Labayru-Echeverría C; Pérez-Ayala A; Ayats J; Cobo F; Pazos C; López-Soria L; Alastruey-Izquierdo A; Muñoz P; Guinea J;
Clin Microbiol Infect; 2021 Aug; 27(8):1170.e1-1170.e7. PubMed ID: 33010446
[TBL] [Abstract][Full Text] [Related]
20.
Talbot JJ; Frisvad JC; Meis JF; Hagen F; Verweij PE; Hibbs DE; Lai F; Groundwater PW; Samson RA; Kidd SE; Barrs VR; Houbraken J
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
